Paradoxically, the circulating level of FGF21 is higher, but adiponectin level is lower in individuals with NAFLD, suggesting a state of adipose tissue FGF21 resistance (17, 20–23). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.